Compare PARR & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PARR | INSP |
|---|---|---|
| Founded | 1984 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.2B |
| IPO Year | 2000 | 2018 |
| Metric | PARR | INSP |
|---|---|---|
| Price | $48.87 | $62.37 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 16 |
| Target Price | $46.20 | ★ $101.07 |
| AVG Volume (30 Days) | 1.1M | ★ 1.4M |
| Earning Date | 05-26-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1313.56 | 179.43 |
| EPS | ★ 7.16 | 4.89 |
| Revenue | ★ $2,443,066,000.00 | $82,050,000.00 |
| Revenue This Year | N/A | $8.44 |
| Revenue Next Year | $4.98 | $8.60 |
| P/E Ratio | ★ $6.99 | $12.82 |
| Revenue Growth | 30.99 | ★ 62.18 |
| 52 Week Low | $12.04 | $53.11 |
| 52 Week High | $51.55 | $189.49 |
| Indicator | PARR | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 67.42 | 40.34 |
| Support Level | $33.67 | $55.34 |
| Resistance Level | N/A | $84.26 |
| Average True Range (ATR) | 2.41 | 4.51 |
| MACD | 0.76 | 1.45 |
| Stochastic Oscillator | 80.94 | 18.64 |
Par Pacific Holdings Inc is an oil and gas company that manages and maintains interests in energy and infrastructure businesses. The company has three reportable segments namely Refining, Under its refining business, the company produces ultra-low-sulfur diesel, gasoline, jet fuel, marine fuel, LSFO, and other associated refined products. Its Retail includes operation licenses out brands to serve the retail consumer. Through the Logistics segment, crude shipments are delivered to the refineries, in addition to finished products that are exported. It generates maximum revenue from the Refining segment.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.